3 ms·

>AI software that helps doctors diagnose diabetic retinopathy like specialists is approved by FDA (theverge.com)

• derefr 8y ago
  Well, sure, but the software's architecture probably isn't too particular to this use-case; it's just computer vision. Given FDA approval for using CV for this, we'll probably quickly see many other companies attempting to drive similar technologies to market. Or, rather, we would if there were any existing companies in this space that could take advantage of this. The creator of this device, IDx (https://www.eyediagnosis.net https://www.eyediagnosis.net), seems to be rather unique in being an entrepreneurial medical-device manufacturer; MDMs are a rather hide-bound lot. Honestly, if there's going to be a wave of innovation in this space, I might expect it to come from the inorganic-chem-focused pharma companies, since they have the expertise in both materials science and machine-learning (from doing novel small-molecule detection studies) required to come up with the innovations. I expect they'd likely partner with one or more of the MDMs to build the hardware, but they would write the software.